Cash flow Celanese Corporation

Equities

CE

US1508701034

Specialty Chemicals

Market Closed - Nyse Other stock markets 21:00:02 15/04/2026 BST			5-day change	1st Jan Change
64.73 ^USD	-0.57%		+1.82%	+53.10%

04-15	Celanese Keeps Quarterly Dividend at $0.03 per Share, Payable May 11 to Shareholders of Record on April 27	MT
04-14	Corteva, Inc. Announces Management Changes	CI

568fa52d660f8e0fdc.0RcpTxi7sSUoH-HYeSD2dGEHxgxiJQSkkpKue8BRI4s.kyJ2FkL2hkRGWqKIFkKcGDhkk30TYk_P-8LlOJUVVdulUm18YdjmZhl0kg

Published financial data: CELANESE CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	8.54B	9.67B	10.94B	10.28B	9.54B
Total Revenues	8.54B	9.67B	10.94B	10.28B	9.54B
Cost of Goods Sold, Total	5.86B	7.29B	8.34B	7.85B	7.58B
Gross Profit	2.68B	2.38B	2.6B	2.43B	1.96B
Selling General & Admin Expenses, Total	527M	690M	1.14B	1.05B	844M
R&D Expenses	86M	112M	146M	130M	125M
Amortization of Goodwill and Intangible Assets - (IS)	25M	62M	164M	159M	164M
Other Operating Expenses	-	-	-	-	-
Other Operating Expenses, Total	638M	864M	1.45B	1.34B	1.13B
Operating Income	2.04B	1.52B	1.15B	1.09B	830M
Interest Expense, Total	-91M	-405M	-720M	-676M	-701M
Interest And Investment Income	155M	202M	165M	161M	146M
Net Interest Expenses	64M	-203M	-555M	-515M	-555M
Income (Loss) On Equity Invest.	146M	220M	102M	196M	127M
Currency Exchange Gains (Loss)	2M	-2M	-19M	-26M	36M
Other Non Operating Income (Expenses)	-5M	10M	76M	90M	7M
EBT, Excl. Unusual Items	2.25B	1.54B	753M	833M	445M
Restructuring Charges	5M	6M	-53M	-176M	-79M
Merger & Related Restructuring Charges	-	-117M	-	-	-
Impairment of Goodwill	-	-	-	-	-1.14B
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	3M	5M	505M	-14M	-5M
Asset Writedown	-2M	-14M	-15M	-1.64B	-373M
Legal Settlements	-	-	-	-	-
Other Unusual Items	-9M	-	-7M	-	-68M
EBT, Incl. Unusual Items	2.25B	1.42B	1.18B	-996M	-1.22B
Income Tax Expense	330M	-489M	-790M	510M	-90M
Earnings From Continuing Operations	1.92B	1.91B	1.97B	-1.51B	-1.13B
Earnings Of Discontinued Operations	-22M	-8M	-9M	-8M	-21M
Net Income to Company	1.9B	1.9B	1.96B	-1.51B	-1.15B
Minority Interest	-6M	-8M	-4M	-8M	-14M
Net Income - (IS)	1.89B	1.89B	1.96B	-1.52B	-1.16B
Net Income to Common Incl Extra Items	1.89B	1.89B	1.96B	-1.52B	-1.16B
Net Income to Common Excl. Extra Items	1.91B	1.9B	1.97B	-1.51B	-1.14B
Per Share Items
Net EPS - Basic	16.99	17.48	18.01	-13.93	-10.64
Basic EPS - Continuing Operations	17.19	17.55	18.09	-13.86	-10.44
Basic Weighted Average Shares Outstanding	111M	108M	109M	109M	110M
Net EPS - Diluted	16.86	17.34	17.92	-13.93	-10.64
Diluted EPS - Continuing Operations	17.06	17.41	18	-13.86	-10.44
Diluted Weighted Average Shares Outstanding	112M	109M	109M	109M	110M
Normalized Basic EPS	12.6	8.81	4.29	4.69	2.41
Normalized Diluted EPS	12.5	8.74	4.27	4.69	2.41
Dividend Per Share	2.72	2.74	2.8	2.8	0.12
Payout Ratio	16.08	15.68	15.56	-20.17	-1.12
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	2.42B	1.98B	1.83B	1.8B	1.56B
EBITA	2.07B	1.57B	1.27B	1.2B	952M
EBIT	2.04B	1.52B	1.15B	1.09B	830M
EBITDAR	2.49B	2.07B	1.96B	1.93B	1.69B
Effective Tax Rate - (Ratio)	14.68	-34.41	-66.78	-51.2	7.38
Current Domestic Taxes	-	54M	8M	79M	3M
Current Foreign Taxes	323M	306M	162M	239M	158M
Total Current Taxes	323M	360M	170M	318M	161M
Deferred Domestic Taxes	-16M	-261M	-178M	-87M	-107M
Deferred Foreign Taxes	23M	-588M	-782M	279M	-144M
Total Deferred Taxes	7M	-849M	-960M	192M	-251M
Normalized Net Income	1.4B	955M	467M	513M	264M
Interest Capitalized	12M	18M	37M	30M	24M
Interest on Long-Term Debt	34M	29M	54M	38M	99M
Non-Cash Pension Expense	-101M	-8M	64M	22M	-58M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	89M	121M	189M	172M	167M
Net Rental Expense, Total	70M	98M	131M	134M	124M
Imputed Operating Lease Interest Expense	13.98M	34.31M	54.29M	55.96M	55.57M
Imputed Operating Lease Depreciation	56.02M	63.69M	76.71M	78.04M	68.43M
Stock-Based Comp., Other (Total)	95M	60M	40M	32M	24M
Total Stock-Based Compensation	95M	60M	40M	32M	24M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	536M	1.51B	1.8B	962M	1.26B
Short Term Investments	10M	-	-	-	-
Total Cash And Short Term Investments	546M	1.51B	1.8B	962M	1.26B
Accounts Receivable, Total	1.16B	1.38B	1.24B	1.12B	922M
Other Receivables	506M	675M	541M	493M	545M
Total Receivables	1.67B	2.05B	1.78B	1.61B	1.47B
Inventory	1.52B	2.81B	2.36B	2.28B	2.22B
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	70M	241M	272M	285M	743M
Total Current Assets	3.81B	6.61B	6.22B	5.14B	5.69B
Gross Property Plant And Equipment	7.91B	9.68B	10.09B	10.22B	10.67B
Accumulated Depreciation	-3.48B	-3.69B	-4.08B	-4.56B	-5.24B
Net Property Plant And Equipment	4.43B	6B	6.01B	5.66B	5.44B
Long-term Investments	823M	1.06B	1.22B	1.22B	1.25B
Goodwill	1.41B	7.14B	6.98B	5.39B	4.17B
Other Intangibles, Total	735M	4.1B	3.98B	3.64B	3.18B
Deferred Tax Assets Long-Term	248M	808M	1.68B	1.25B	1.36B
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	521M	547M	524M	555M	601M
Total Assets	11.98B	26.27B	26.6B	22.86B	21.7B
Liabilities
Accounts Payable, Total	1.16B	1.52B	1.51B	1.23B	1.28B
Accrued Expenses, Total	323M	650M	670M	655M	593M
Short-term Borrowings	264M	800M	358M	108M	90M
Current Portion of Long-Term Debt	502M	481M	1B	1.37B	1.09B
Current Portion of Leases	62M	108M	113M	102M	94M
Current Income Taxes Payable	81M	43M	25M	4M	76M
Other Current Liabilities	113M	468M	395M	386M	460M
Total Current Liabilities	2.5B	4.07B	4.07B	3.85B	3.68B
Long-Term Debt	3.03B	13.23B	12.18B	10.96B	11.29B
Long-Term Leases	348M	511M	449M	416M	371M
Unearned Revenue Non Current	-	-	-	-	-
Pension & Other Post Retirement Benefits	558M	411M	457M	396M	344M
Deferred Tax Liability Non Current	555M	1.24B	999M	933M	512M
Other Non Current Liabilities	444M	709M	891M	694M	1.02B
Total Liabilities	7.44B	20.17B	19.04B	17.25B	17.22B
Additional Paid In Capital	333M	372M	394M	409M	431M
Retained Earnings	9.68B	11.27B	12.93B	11.1B	9.88B
Treasury Stock	-5.49B	-5.49B	-5.49B	-5.49B	-5.48B
Comprehensive Income and Other	-329M	-518M	-744M	-848M	-776M
Total Common Equity	4.19B	5.64B	7.09B	5.18B	4.05B
Minority Interest	348M	468M	461M	434M	423M
Total Equity	4.54B	6.1B	7.55B	5.61B	4.47B
Total Liabilities And Equity	11.98B	26.27B	26.6B	22.86B	21.7B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	108M	108M	109M	109M	110M
ECS Total Common Shares Outstanding	108M	108M	109M	109M	110M
Book Value / Share	38.78	51.97	65.11	47.33	36.95
Tangible Book Value	2.04B	-5.61B	-3.86B	-3.85B	-3.31B
Tangible Book Value Per Share	18.9	-51.72	-35.45	-35.24	-30.17
Total Debt	4.2B	15.13B	14.1B	12.95B	12.93B
Net Debt	3.66B	13.62B	12.29B	11.99B	11.67B
Debt Equivalent of Unfunded Proj. Benefit Obligation	305M	233M	271M	245M	170M
Debt Equivalent Oper. Leases	560M	784M	1.05B	1.07B	992M
Minority Interest, Total (Incl. Fin. Div)	348M	468M	461M	434M	423M
Equity Method Investments, Total	823M	1.06B	1.22B	1.22B	1.25B
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	435M	786M	593M	560M	487M
Inventories - Work In Process, Total	75M	202M	160M	119M	89M
Inventories - Finished Goods, Total	1.01B	1.82B	1.6B	1.6B	1.64B
Land - (BS)	48M	291M	260M	240M	199M
Buildings, Total	820M	1.06B	1.08B	1.06B	1.17B
Machinery, Total	5.64B	6.9B	7.16B	7.74B	8.26B
Full Time Employees	8.53K	13.26K	12.41K	12.16K	11.43K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	10M	15M	12M	16M	18M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	1.89B	1.89B	1.96B	-1.52B	-1.16B
Depreciation & Amortization - CF	353M	406M	561M	593M	611M
Amortization of Goodwill and Intangible Assets - (CF)	22M	53M	121M	117M	122M
Depreciation & Amortization, Total	375M	459M	682M	710M	733M
Amortization of Deferred Charges, Total - (CF)	3M	9M	43M	42M	42M
(Gain) Loss From Sale Of Asset	-5M	-8M	-501M	13M	5M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	2M	24M	29M	1.71B	1.52B
(Income) Loss On Equity Investments - (CF)	-34M	-3M	55M	-33M	13M
Stock-Based Compensation (CF)	95M	60M	40M	32M	24M
Net Cash From Discontinued Operations	15M	-28M	-2M	-5M	12M
Other Operating Activities, Total	-96M	-868M	-923M	223M	-277M
Change In Accounts Receivable	-396M	218M	105M	92M	213M
Change In Inventories	-367M	-253M	398M	11M	154M
Change In Accounts Payable	353M	-84M	20M	-234M	26M
Change in Other Net Operating Assets	-78M	399M	-7M	-73M	-158M
Cash from Operations	1.76B	1.82B	1.9B	966M	1.15B
Capital Expenditure	-467M	-543M	-568M	-435M	-343M
Cash Acquisitions	-1.14B	-10.59B	52M	-	-
Divestitures	27M	48M	480M	-	21M
Investment in Marketable and Equity Securities, Total	516M	-	-	-	-
Other Investing Activities, Total	-53M	-57M	-98M	-35M	-27M
Cash from Investing	-1.12B	-11.14B	-134M	-470M	-349M
Short Term Debt Issued, Total	206M	536M	452M	175M	614M
Long-Term Debt Issued, Total	990M	10.77B	3B	328M	4.35B
Total Debt Issued	1.2B	11.3B	3.45B	503M	4.97B
Short Term Debt Repaid, Total	-6M	-	-881M	-418M	-637M
Long-Term Debt Repaid, Total	-786M	-526M	-3.66B	-1.03B	-4.65B
Total Debt Repaid	-792M	-526M	-4.54B	-1.45B	-5.29B
Issuance of Common Stock	-	-	-	1M	-
Repurchase of Common Stock	-1B	-17M	-	-	-
Common Dividends Paid	-304M	-297M	-305M	-307M	-13M
Common & Preferred Stock Dividends Paid	-304M	-297M	-305M	-307M	-13M
Other Financing Activities, Total	-142M	-175M	-63M	-59M	-177M
Cash from Financing	-1.04B	10.29B	-1.46B	-1.31B	-513M
Foreign Exchange Rate Adjustments	-15M	4M	-12M	-26M	17M
Net Change in Cash	-419M	972M	297M	-843M	301M
Supplemental Items
Cash Interest Paid	105M	122M	780M	701M	671M
Cash Income Tax Paid (Refund)	215M	273M	237M	349M	255M
Levered Free Cash Flow	558M	-151M	1.08B	510M	369M
Unlevered Free Cash Flow	614M	102M	1.53B	932M	807M
Change In Net Working Capital	669M	830M	-611M	97M	168M
Net Debt Issued / Repaid	404M	10.78B	-1.09B	-948M	-323M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	11.16	4.95	2.72	2.75	2.33
Return on Total Capital	15.31	6.32	3.35	3.38	2.89
Return On Equity %	45.49	35.9	28.89	-22.89	-22.52
Return on Common Equity	49.57	38.71	30.94	-24.69	-24.93
Margin Analysis
Gross Profit Margin %	31.42	24.6	23.79	23.61	20.57
SG&A Margin	6.17	7.13	10.46	10.21	8.84
EBITDA Margin %	28.34	20.42	16.74	17.49	16.38
EBITA Margin %	24.2	16.22	11.61	11.72	9.97
EBIT Margin %	23.94	15.67	10.5	10.58	8.7
Income From Continuing Operations Margin %	22.47	19.75	18.03	-14.65	-11.84
Net Income Margin %	22.14	19.58	17.92	-14.81	-12.21
Net Avail. For Common Margin %	22.4	19.66	18	-14.73	-11.99
Normalized Net Income Margin	16.41	9.87	4.27	4.99	2.77
Levered Free Cash Flow Margin	6.53	-1.56	9.84	4.96	3.86
Unlevered Free Cash Flow Margin	7.2	1.06	13.95	9.07	8.45
Asset Turnover
Asset Turnover	0.75	0.51	0.41	0.42	0.43
Fixed Assets Turnover	1.99	1.86	1.82	1.76	1.72
Receivables Turnover (Average Receivables)	8.74	7.62	8.34	8.7	9.34
Inventory Turnover (Average Inventory)	4.68	3.37	3.23	3.38	3.37
Short Term Liquidity
Current Ratio	1.52	1.63	1.53	1.34	1.55
Quick Ratio	0.88	0.88	0.88	0.67	0.74
Operating Cash Flow to Current Liabilities	0.7	0.45	0.47	0.25	0.31
Days Sales Outstanding (Average Receivables)	41.75	47.92	43.74	42.08	39.07
Days Outstanding Inventory (Average Inventory)	77.99	108.4	113.06	108.15	108.43
Average Days Payable Outstanding	55.8	56.98	70.07	64.4	60.87
Cash Conversion Cycle (Average Days)	63.94	99.34	86.73	85.83	86.63
Long Term Solvency
Total Debt/Equity	92.66	247.76	186.68	230.91	289.22
Total Debt / Total Capital	48.1	71.24	65.12	69.78	74.31
LT Debt/Equity	74.41	225.01	167.19	202.75	260.71
Long-Term Debt / Total Capital	38.62	64.7	58.32	61.27	66.98
Total Liabilities / Total Assets	62.11	76.76	71.61	75.46	79.39
EBIT / Interest Expense	22.46	3.74	1.6	1.61	1.18
EBITDA / Interest Expense	27.35	5.12	2.72	2.86	2.41
(EBITDA - Capex) / Interest Expense	22.22	3.78	1.94	2.21	1.92
Total Debt / EBITDA	1.69	7.3	7.19	6.7	7.67
Net Debt / EBITDA	1.47	6.57	6.27	6.21	6.92
Total Debt / (EBITDA - Capex)	2.08	9.89	10.11	8.65	9.62
Net Debt / (EBITDA - Capex)	1.81	8.9	8.82	8.01	8.68
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	50.96	13.31	13.1	-6.03	-7.05
Gross Profit, 1 Yr. Growth %	107.42	-11.26	9.37	-6.76	-18.45
EBITDA, 1 Yr. Growth %	122.54	-18.35	-7.76	-2.55	-11.94
EBITA, 1 Yr. Growth %	174.37	-24.06	-19.06	-5.12	-19.46
EBIT, 1 Yr. Growth %	178.47	-25.83	-24.21	-5.31	-22.07
Earnings From Cont. Operations, 1 Yr. Growth %	-4.29	-0.42	3.3	-176.33	-25.95
Net Income, 1 Yr. Growth %	-4.79	0.21	3.48	-177.65	-24.45
Normalized Net Income, 1 Yr. Growth %	154.76	-31.82	-51.15	9.86	-46.99
Diluted EPS Before Extra, 1 Yr. Growth %	1.25	2.05	3.39	-177	-25.61
Accounts Receivable, 1 Yr. Growth %	46.59	18.78	-9.86	-9.82	-17.75
Inventory, 1 Yr. Growth %	55.83	84.25	-16.06	-3.1	-2.8
Net Property, Plant and Equip., 1 Yr. Growth %	6.19	35.4	0.15	-5.74	-3.99
Total Assets, 1 Yr. Growth %	9.77	119.39	1.24	-14.06	-5
Tangible Book Value, 1 Yr. Growth %	0.05	-374.73	-31.18	-0.21	-15.21
Common Equity, 1 Yr. Growth %	18.8	34.57	25.79	-27.02	-21.06
Cash From Operations, 1 Yr. Growth %	30.83	3.53	4.4	-49.13	18.63
Capital Expenditures, 1 Yr. Growth %	28.3	16.27	4.6	-23.42	-21.15
Levered Free Cash Flow, 1 Yr. Growth %	5.49	-127.51	-865.24	-53.26	-33.11
Unlevered Free Cash Flow, 1 Yr. Growth %	2.97	-83.04	1.26K	-39.49	-17.14
Dividend Per Share, 1 Yr. Growth %	9.68	0.74	2.19	0	-95.71
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	16.44	30.79	13.2	3.09	-6.54
Gross Profit, 2 Yr. CAGR %	29.23	35.67	-1.48	0.98	-13.06
EBITDA, 2 Yr. CAGR %	32.93	34.61	-13.05	-5.04	-8.48
EBITA, 2 Yr. CAGR %	41.15	44.06	-21.65	-12.61	-8.66
EBIT, 2 Yr. CAGR %	42.05	43.71	-25.02	-15.28	-14.71
Earnings From Cont. Operations, 2 Yr. CAGR %	48.99	-2.37	1.42	-11.2	-23.99
Net Income, 2 Yr. CAGR %	48.94	-2.32	1.84	-10.36	-22.57
Normalized Net Income, 2 Yr. CAGR %	37.33	31.79	-42.29	-26.74	-24.36
Diluted EPS Before Extra, 2 Yr. CAGR %	57.35	1.65	2.72	-10.78	-23.48
Accounts Receivable, 2 Yr. CAGR %	16.87	31.95	3.47	-9.84	-13.87
Inventory, 2 Yr. CAGR %	21.17	69.45	24.36	-9.81	-2.95
Net Property, Plant and Equip., 2 Yr. CAGR %	6.35	19.91	16.45	-2.84	-4.87
Total Assets, 2 Yr. CAGR %	12.42	55.19	49.03	-6.73	-9.68
Tangible Book Value, 2 Yr. CAGR %	34.97	65.79	37.51	-17.13	-7.47
Common Equity, 2 Yr. CAGR %	29.26	26.44	30.11	-4.19	-24.44
Cash From Operations, 2 Yr. CAGR %	9.93	16.38	3.96	-27.13	-22.32
Capital Expenditures, 2 Yr. CAGR %	12.35	22.14	10.28	-10.5	-22.29
Levered Free Cash Flow, 2 Yr. CAGR %	-13.67	-46.62	40.18	90.34	-41.34
Unlevered Free Cash Flow, 2 Yr. CAGR %	-13.44	-58.56	58.89	187.83	-27.17
Dividend Per Share, 2 Yr. CAGR %	6.46	5.11	1.46	1.09	-79.3
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	6.06	15.38	24.6	6.39	-0.45
Gross Profit, 3 Yr. CAGR %	10.79	14.01	26.27	-3.28	-6.22
EBITDA, 3 Yr. CAGR %	14.46	12.99	18.87	-9.45	-7.8
EBITA, 3 Yr. CAGR %	16.88	14.8	18.88	-16.49	-15.5
EBIT, 3 Yr. CAGR %	17.19	14.38	16.11	-18.96	-18.19
Earnings From Cont. Operations, 3 Yr. CAGR %	16.34	30.27	-0.52	-7.74	-16.05
Net Income, 3 Yr. CAGR %	16.12	30.51	-0.42	-6.96	-14.96
Normalized Net Income, 3 Yr. CAGR %	14.34	8.74	-5.33	-28.47	-34.85
Diluted EPS Before Extra, 3 Yr. CAGR %	23.99	36.2	2.23	-6.69	-15.66
Accounts Receivable, 3 Yr. CAGR %	4.51	17.5	16.21	-1.16	-12.56
Inventory, 3 Yr. CAGR %	13.37	39.34	34.07	14.44	-7.53
Net Property, Plant and Equip., 3 Yr. CAGR %	6	15.26	12.92	8.52	-3.23
Total Assets, 3 Yr. CAGR %	8.74	40.48	34.59	24.05	-6.18
Tangible Book Value, 3 Yr. CAGR %	8.09	71.05	23.68	23.57	-16.16
Common Equity, 3 Yr. CAGR %	11.97	31.01	26.22	7.3	-10.44
Cash From Operations, 3 Yr. CAGR %	4.09	7.75	12.24	-18.08	-14.27
Capital Expenditures, 3 Yr. CAGR %	11.49	13.64	15.99	-2.34	-14.2
Levered Free Cash Flow, 3 Yr. CAGR %	-1.45	-41.39	26.74	-2.38	37.88
Unlevered Free Cash Flow, 3 Yr. CAGR %	-2.09	-50	36.75	15.52	92.84
Dividend Per Share, 3 Yr. CAGR %	9.35	4.52	4.13	0.97	-64.75
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	9.64	9.52	8.86	10.3	11.03
Gross Profit, 5 Yr. CAGR %	13.8	9.51	5.71	8.61	8.71
EBITDA, 5 Yr. CAGR %	15.24	9.18	2.57	5.6	7.47
EBITA, 5 Yr. CAGR %	17.82	9.69	-0.37	3.05	4.72
EBIT, 5 Yr. CAGR %	17.78	9.41	-1.98	1.44	2.49
Earnings From Cont. Operations, 5 Yr. CAGR %	16.13	17.25	10.13	11.75	-10.83
Net Income, 5 Yr. CAGR %	16	17.57	10.18	12.3	-10.11
Normalized Net Income, 5 Yr. CAGR %	16.73	6.22	-13.02	-7.15	-13.64
Diluted EPS Before Extra, 5 Yr. CAGR %	22.48	22.98	15	15	-9.12
Accounts Receivable, 5 Yr. CAGR %	7.71	6.94	4.1	5.69	3.09
Inventory, 5 Yr. CAGR %	16.18	25.55	17.64	17.08	17.82
Net Property, Plant and Equip., 5 Yr. CAGR %	4.37	9.77	10.06	7.65	5.44
Total Assets, 5 Yr. CAGR %	7.46	22.46	23.35	19.26	14.74
Tangible Book Value, 5 Yr. CAGR %	5.03	28.79	19.01	28.01	10.13
Common Equity, 5 Yr. CAGR %	10.11	14.32	18.9	15.6	2.8
Cash From Operations, 5 Yr. CAGR %	14.49	17.77	4.04	-7.85	-3.12
Capital Expenditures, 5 Yr. CAGR %	13.68	15.25	11.01	3.29	-1.18
Levered Free Cash Flow, 5 Yr. CAGR %	3.67	-21.68	13.06	-7.4	-6.96
Unlevered Free Cash Flow, 5 Yr. CAGR %	2.78	-29.38	18.44	2.59	6.22
Dividend Per Share, 5 Yr. CAGR %	14.53	9.51	6.13	3.13	-45.43